Literature DB >> 24661258

Variations of the corona HDL:albumin ratio determine distinct effects of amorphous SiO2 nanoparticles on monocytes and macrophages in serum.

Chiara Fedeli1, Daniela Segat, Regina Tavano, Giorgia De Franceschi, Patrizia Polverino de Laureto, Elisa Lubian, Francesco Selvestrel, Fabrizio Mancin, Emanuele Papini.   

Abstract

AIM: We investigated monocyte and macrophage death and cytokine production induced by amorphous silica nanoparticles (SiO2-NPs) to clarify the role of defined serum corona proteins. MATERIALS &
METHODS: The cytotoxic proinflammatory effects of SiO2-NPs on human monocytes and macrophages were characterized in no serum, in fetal calf serum and in the presence of purified corona proteins.
RESULTS: In no serum and in fetal calf serum above approximately 75 µg/ml, SiO2-NPs lysed monocytes and macrophages by plasma membrane damage (necrosis). In fetal calf serum below approximately 75 µg/ml, SiO2-NPs triggered an endolysosomal acidification and caspase-1-dependent monocyte death (pyroptosis). The corona high-density lipoproteins:albumin ratio accounted for the features of the SiO2-NPs in serum. DISCUSSION: Corona high-density lipoproteins are a major determinant of the differential cytotoxic action of SiO2-NPs on monocytes and macrophages.

Entities:  

Keywords:  HDL; amorphous silica nanoparticle; macrophage; monocyte; nanoparticle protein corona; pyroptosis

Mesh:

Substances:

Year:  2014        PMID: 24661258     DOI: 10.2217/nnm.14.22

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  7 in total

1.  C1q-Mediated Complement Activation and C3 Opsonization Trigger Recognition of Stealth Poly(2-methyl-2-oxazoline)-Coated Silica Nanoparticles by Human Phagocytes.

Authors:  Regina Tavano; Luca Gabrielli; Elisa Lubian; Chiara Fedeli; Silvia Visentin; Patrizia Polverino De Laureto; Giorgio Arrigoni; Alessandra Geffner-Smith; Fangfang Chen; Dmitri Simberg; Giulia Morgese; Edmondo M Benetti; Linping Wu; Seyed Moein Moghimi; Fabrizio Mancin; Emanuele Papini
Journal:  ACS Nano       Date:  2018-05-23       Impact factor: 15.881

2.  Pyrogenic and Precipitated Amorphous Silica Nanoparticles Differentially Affect Cell Responses to LPS in Human Macrophages.

Authors:  Massimiliano Bianchi; Martina Chiu; Giuseppe Taurino; Roberta Ruotolo; Nelson Marmiroli; Enrico Bergamaschi; Francesco Cubadda; Ovidio Bussolati
Journal:  Nanomaterials (Basel)       Date:  2020-07-18       Impact factor: 5.076

3.  Biomolecular Corona Stability in Association with Plasma Cholesterol Level.

Authors:  Duong N Trinh; Meda Radlinskaite; Jack Cheeseman; Gunter Kuhnle; Helen M I Osborn; Paula Meleady; Daniel I R Spencer; Marco P Monopoli
Journal:  Nanomaterials (Basel)       Date:  2022-08-03       Impact factor: 5.719

Review 4.  The Yin and Yang of the protein corona on the delivery journey of nanoparticles.

Authors:  Yi-Feng Wang; Yaxin Zhou; JiaBei Sun; Xiaotong Wang; Yaru Jia; Kun Ge; Yan Yan; Kenneth A Dawson; Shutao Guo; Jinchao Zhang; Xing-Jie Liang
Journal:  Nano Res       Date:  2022-09-16       Impact factor: 10.269

Review 5.  Novel Approaches of Dysregulating Lysosome Functions in Cancer Cells by Specific Drugs and Its Nanoformulations: A Smart Approach of Modern Therapeutics.

Authors:  Khaled S Allemailem; Ahmad Almatroudi; Faris Alrumaihi; Saleh A Almatroodi; Mohammad O Alkurbi; Ghaiyda Talal Basfar; Arshad Husain Rahmani; Amjad Ali Khan
Journal:  Int J Nanomedicine       Date:  2021-07-26

6.  Oxidative Damage and Energy Metabolism Disorder Contribute to the Hemolytic Effect of Amorphous Silica Nanoparticles.

Authors:  Lizhen Jiang; Yongbo Yu; Yang Li; Yang Yu; Junchao Duan; Yang Zou; Qiuling Li; Zhiwei Sun
Journal:  Nanoscale Res Lett       Date:  2016-02-02       Impact factor: 4.703

Review 7.  Opsonins and Dysopsonins of Nanoparticles: Facts, Concepts, and Methodological Guidelines.

Authors:  Emanuele Papini; Regina Tavano; Fabrizio Mancin
Journal:  Front Immunol       Date:  2020-10-12       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.